{
    "title": "UPDATE 4-Gilead buys Forty Seven for $4.9 bln to bolster cancer drug pipeline",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8065309/Gilead-buy-drug-developer-Forty-Seven-4-9-bln.html",
    "date": "2020-03-02",
    "keywords": [
        "gilead",
        "inc",
        "treatment",
        "acquisition",
        "magrolimab",
        "market",
        "dlbcl",
        "trisha",
        "blood",
        "cancer",
        "portfolio",
        "trading",
        "offer",
        "share",
        "deal",
        "drug",
        "cart",
        "therapy",
        "future",
        "march",
        "monday",
        "cash",
        "oncology",
        "price",
        "morning",
        "pharma",
        "company",
        "time",
        "fall",
        "line",
        "strategy",
        "ceo",
        "daniel",
        "oday",
        "year",
        "management",
        "need",
        "something",
        "credit",
        "analyst",
        "evan",
        "seigerman",
        "access",
        "cd47",
        "tumor",
        "destruction",
        "earlystage",
        "class",
        "development",
        "officer",
        "merdad",
        "parsey",
        "bcell",
        "lymphoma",
        "type",
        "yescarta",
        "kite",
        "suntrust",
        "thursday",
        "news",
        "report",
        "takeover",
        "forty",
        "karnauskas",
        "goonewardene",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "chakrabarty",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}